Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Interim Management Statement

19 May 2009 07:00

Chesnara plc - Interim Management Statement

Chesnara plc

Interim Management Statement for the period from 1 January 2009 to 18 May 2009

19 May 2009

This statement is to update investors on the financial position of Chesnara plc (the `Group') as at 31 March 2009 and on its financial performance during the first quarter. Where events and transactions have occurred since the first quarter end, which are estimated to have a material impact on management's core expectation of the financial position and financial performance of the Group, then these are identified, together with a broad indication of their impact.

The key determinant of Group performance in the first quarter was the continuing decline in investment markets, with the leading UK equity market indices showing an 11% reduction over the period and with returns on cash deposits reducing. The effect of these factors was a £6.4m net of tax reduction in European Embedded Value (`EEV'). However, the subsequent recovery in equity investment markets, which has, up until 16 May 2009, virtually eliminated all of the first quarter decline, is estimated to have offset the net of tax reduction in EEV by some £3.6m.

In addition, a widening of the differential between gilt returns and swap rates has, in the absence of the re-calibration of the Risk Discount Rate (RDR) used to discount the cash flows underlying the value in-force component of EEV, led to a further net of tax reduction in the order of £3.8m in EEV. It is expected that this effect will be largely reversed when the RDR is next re-calibrated as at 30 June 2009.

Apart from the impact of market performance in the first quarter, the business is, based on fundamentals, performing ahead of expectations. Key contributors are:

* favourable lapse experience across both investment and protection products, leading to a net of tax EEV increase of £1.3m. * favourable mortality experience, leading to a net of tax EEV increase of £0.5m

With the return from the in-force business, by way of the unwind of the RDR, in line with expectation, the overall position over the quarter is a reduction in the EEV of £6.5m net of tax from £182.7m to £176.2m. Both amounts are stated before adjustment for the appropriation of the final 2008 dividend of £10.2m payable on 20 May 2009. As indicated earlier, the recovery of investment markets since the quarter end and the expected recalibration of the RDR as at 30 June 2009 are together estimated to offset this reduction to the extent of some £7.4m.

In contrast to the volatility of the EEV result, the IFRS result of £4.1m pre-tax (£3.0m net of tax) for the quarter has proved more resilient. While first quarter investment market effects have adversely impacted the pre-tax result by some £2.3m, the impact of this has been sheltered by favourable expense and mortality experience of just under £1.0m pre tax. It is expected that equity investment market recovery from the end of the quarter to 16 May 2009 will have reduced the adverse pre-tax impact by more than £1m.

In terms of solvency, the emergence of surplus from the life business has remained strong such that the ratio of regulatory capital resource to regulatory capital requirements in the life company has improved from 177% as at the 2008 year end to 185% at the end of the first quarter 2009.

Whilst, we remain cautious about the impact of continuing volatility in equity markets and about declining cash deposit yields, the results have clearly benefited from the favourable effects of fundamentals, such as lapses, mortality and expenses.

Acquisition

As announced on 17 April 2009 the Company has agreed to acquire (subject to shareholder approval) Moderna Forsakringar Liv and a circular in relation to this will be sent shortly.

Market Opportunity

We believe that attractively priced assets are now becoming available as a result of turbulence in financial markets. We continue to examine such opportunities as they arise and believe that we have a strong financial platform from which to pursue them and we will continue to apply strict financial and risk criteria to any prospective acquisitions.

Notes to editors:

Chesnara plc, which listed on the London Stock Exchange in May 2004, is the owner of Countrywide Assured plc (`CA'). CA is a life assurance subsidiary that is substantially closed to new business. In June 2005 Chesnara acquired City of Westminster Assurance (`CWA') for GBP47.8m. With effect from 30 June 2006, CWA's policies and assets were transferred into CA plc. Chesnara's operating model is to maintain a relatively small governance team. Chesnara continues to seek acquisition opportunities in the financial services sector in areas related to its core life operations.

For further enquiries, please contact:

Chesnara plcGraham Kettleborough, CEOTel: +44 (0) 7799 407519Press

Michael Henman, Cubitt Consulting

Tel: +44 (0) 207 367 5100

vendor
Date   Source Headline
10th Aug 201511:22 amRNSNotice of Results
20th May 20157:00 amRNSAcquisition
15th May 201511:56 amRNSResult of AGM
11th May 20154:17 pmRNSRegulatory Approval
28th Apr 20153:40 pmRNSDirector/PDMR Shareholding
27th Apr 20159:51 amRNSAnnual Financial Report
15th Apr 20157:00 amRNSAnnual Report and Accounts and Notice of AGM
31st Mar 20157:00 amRNSFinal Results
9th Mar 20158:48 amRNSNotice of Results
25th Feb 20159:29 amRNSHolding(s) in Company
21st Jan 20154:01 pmRNSDirector/PDMR Shareholding
5th Dec 20147:00 amRNSRegulatory Approval
4th Dec 201412:30 pmRNSPart VII Transfer Approval
3rd Dec 201412:58 pmRNSResults of Placing
3rd Dec 20147:01 amRNSProposed Acquisition and Placing
3rd Dec 20147:00 amRNSDirectorate Change
19th Nov 20147:00 amRNSInterim Management Statement
7th Nov 201412:54 pmRNSTotal Voting Rights
4th Nov 201410:18 amRNSDirector/PDMR Shareholdings / Total Voting Rights
9th Sep 20142:39 pmRNSHolding(s) in Company
29th Aug 20147:00 amRNSHalf Yearly Report
11th Aug 20144:01 pmRNSNotice of Results
21st Jul 201411:42 amRNSTotal Voting Rights
7th Jul 20141:41 pmRNSContract with HCL
19th Jun 20142:06 pmRNSDirectorate Change
20th May 20142:43 pmRNSDirector/PDMR Shareholding
19th May 20147:00 amRNS1st Quarter Results
16th May 201411:40 amRNSResult of AGM
28th Apr 201411:42 amRNSAnnual Financial Report
14th Apr 201412:26 pmRNSAnnual Report and Accounts and Notice of AGM
28th Mar 20141:28 pmRNSDirector/PDMR Shareholding
28th Mar 20147:01 amRNSFinal Results
10th Mar 201412:00 pmRNSNotice of Results
3rd Feb 201411:41 amRNSHolding(s) in Company
21st Jan 20141:56 pmRNSHolding(s) in Company
16th Jan 201410:27 amRNSHolding(s) in Company
28th Nov 20132:00 pmRNSAcquisition
19th Nov 20137:00 amRNS3rd Quarter Interim Management Statement
7th Nov 201311:55 amRNSResult of Meeting
22nd Oct 20135:30 pmRNSStatement re: Posting Circular to Shareholders
8th Oct 20137:00 amRNSSale of Direct Line Life & proposed capital return
8th Oct 20137:00 amRNSAcquisition
30th Aug 20137:00 amRNSHalf Yearly Report
12th Aug 20139:42 amRNSNotice of Results
31st Jul 20139:15 amRNSTotal Voting Rights
4th Jul 201310:10 amRNSListing Rule 9.6.14
28th Jun 20139:01 amRNSTotal Voting Rights
11th Jun 20138:30 amRNSDirectorate Change
22nd May 20133:59 pmRNSHolding(s) in Company
17th May 201311:37 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.